This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Efficacy of Triburter on Respiratory Muscle Function in Patients After CABG in Cardiac Rehabilitation Phase II

Sponsored by Fundación Cardiovascular de Colombia

About this trial

Last updated 3 years ago

Study ID

CEI-2022-04334

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18 to 100 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 2 years ago

What is this trial about?

Post-surgery patients have muscle impairments, especially in the respiratory muscles, because the anesthesia, surgical incision, mechanical ventilation, pain, and prolonged postures, affect the mechanical condition of respiratory muscles. Those consequences produce a low exercise tolerance and low quality of life. These patients must go to cardiac rehabilitation to improve heart functions; however, these patients have a weakness in their respiratory muscles. Currently, there are many devices for respiratory muscle strength, although these devices are expensive, and they only have one circuit for training (inspiratory or expiratory). Triburter is a new device with two valves and positive pressure generation, this is a promising alternative because Triburter improves the mechanics of ventilation, increasing their functionality and quality of life. For this reason, the main hypothesis is that respiratory muscle training with Triburter improves the strength of inspiratory and expiratory muscles.

What are the participation requirements?

Yes

Inclusion Criteria

- Patients after Coronary Artery Bypass Graft Surgery

- Older 18 years

- Patients that can able to carry out spirometry and volumen lung measures

- Nyha <2

- Patients in phase 2 of cardiac rehabilitation.

- Absent clinical deterioration

- Mechanical ventilation <24 hours after surgery

No

Exclusion Criteria

- High risk

- Pneumothorax

- Currently in a clinical trial

- Active smokers

- Patients with COPD

- Major complications hospital period

- Neurological diseases or orthopedic diseases

- Patients who can not be able to carry out the lung function measures.

- Patients with CPAP or BiPAP

- Unable to provide

- Informed consent

- Unstable angina

- Decompensated congestive heart failure.

- Cognitive disorder.

- Uncontrolled arrhythmias.

- Uncontrolled arterial hypertension

Locations

Location

Status

Recruiting